National Health Investors, Inc. (NYSE:NHI) stakeholders will be awarded with payout of $0.9 per share. It has fixed record date as 2016-09-30, the payment date is 2016-11-10, and the ex-dividend date is 2016-09-28. This dividend update was issued on 2016-08-08.
In last year National Health Investors, Inc. (NYSE:NHI) paid dividend of $0.9 per share versus the payout of $0.9 a share in the comparable quarter, implying a difference of 10.3896 percent.
The experts are predicting EPS of $1.24. National Health Investors, Inc. (NYSE:NHI) has a price target of $80.75 in short-range. This price is the average of the stock price targets given by 4 analysts. They have the target range of $77 to $84 for the next year. As a result, the standard deviation is calculated at $2.986 after seeing all the price revisions.
Many investors depend on earnings performance to take their investment decisions. Equities are assessed as per their ability to improve earnings and to beat or meet analysts’ consensus projections.
The basic measurement of financial performance is earnings per share. This factor is calculated as the firm’s net earnings/net income found on income statement minus dividends on preferred stock, divided by outstanding shares count. For instance, if a firm generates a net income of $12 million in 3Q and has 8 million shares outstanding, its per-share earnings would be $1.50.
The question is why does the investment group focus on earnings instead of focusing on other metrics such as cash flow or sales? Any financial expert can tell that the proper way to value an equity is to estimate the free cash flow of a firm in long-term, discount them to the present day and later divide by the count of shares.
For the period closed on 2015-12-31, National Health Investors, Inc. (NYSE:NHI) reported EPS of $1.22. The firm can post financials for the quarter ending on 2016-09-30 on or around 2016-11-03.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...